174 related articles for article (PubMed ID: 12074201)
21. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of microorganisms isolated from febrile neutropenic children with neoplastic disease].
Wojak I; Gospodarek E
Med Dosw Mikrobiol; 2004; 56(4):411-9. PubMed ID: 15959998
[TBL] [Abstract][Full Text] [Related]
23. [Microbiological isolates in patients with febrile neutropenia and hematological neoplasias].
Figuera Esparza M; Carballo M; Silva M; Figueredo A; Avilán J
Rev Esp Quimioter; 2006 Sep; 19(3):247-51. PubMed ID: 17099792
[TBL] [Abstract][Full Text] [Related]
24. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
Chayakulkeeree M; Thamlikitkul V
J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
[TBL] [Abstract][Full Text] [Related]
25. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Hamidah A; Lim YS; Zulkifli SZ; Zarina AL; Nordiah AJ; Jamal R
Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821
[TBL] [Abstract][Full Text] [Related]
26. [Bacteremia in children with tumors or malignant diseases 1991-2000].
Alfredsdóttir IH; Thors VS; Gudnason T; Jónmundsson G; Kristinsson JR; Jónsson OG; Kristinsson KG; Haraldsson A
Laeknabladid; 2008 Jul; 94(7-8):531-9. PubMed ID: 18591728
[TBL] [Abstract][Full Text] [Related]
27. Clinical implications of icaA and icaD genes in coagulase negative staphylococci and Staphylococcus aureus bacteremia in febrile neutropenic pediatric cancer patients.
El-Mahallawy HA; Loutfy SA; El-Wakil M; El-Al AK; Morcos H
Pediatr Blood Cancer; 2009 Jul; 52(7):824-8. PubMed ID: 19214976
[TBL] [Abstract][Full Text] [Related]
28. [Management of 315neutropenic febrile episodes in a cancer center].
Dutronc H; Billhot M; Dupon M; Eghbali H; Donamaria C; Dauchy FA; Reiffers J
Med Mal Infect; 2009 Jun; 39(6):388-93. PubMed ID: 19062208
[TBL] [Abstract][Full Text] [Related]
29. Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern.
Butt T; Afzal RK; Ahmad RN; Salman M; Mahmood A; Anwar M
J Ayub Med Coll Abbottabad; 2004; 16(1):18-22. PubMed ID: 15125174
[TBL] [Abstract][Full Text] [Related]
30. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
[TBL] [Abstract][Full Text] [Related]
31. Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern.
Mokuolu AO; Jiya N; Adesiyun OO
Afr J Med Med Sci; 2002 Jun; 31(2):127-30. PubMed ID: 12518907
[TBL] [Abstract][Full Text] [Related]
32. [Microbiological characteristics of pathogens causing bacteremia among hospitalized pediatric oncology patients with fever and neutropenia].
Leibson T; Ben-Shimol S; Hazan G; Fruchtman Y; Kapelushnik J; Greenberg D
Harefuah; 2012 Oct; 151(10):592-6, 603-4. PubMed ID: 23316669
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia.
Castagnola E; Caviglia I; Pescetto L; Bagnasco F; Haupt R; Bandettini R
Future Microbiol; 2015; 10(3):357-64. PubMed ID: 25812459
[TBL] [Abstract][Full Text] [Related]
34. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer.
El-Mahallawy HA; El-Wakil M; Moneer MM; Shalaby L
Pediatr Blood Cancer; 2011 Aug; 57(2):283-8. PubMed ID: 21671364
[TBL] [Abstract][Full Text] [Related]
36. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies.
Avabratha KS; Rau AT; Venkataravanamma P; Rau A
Indian Pediatr; 2009 Sep; 46(9):797-9. PubMed ID: 19430077
[TBL] [Abstract][Full Text] [Related]
37. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
[TBL] [Abstract][Full Text] [Related]
38. Nosocomial bloodstream infections in children and adolescents in southern Israel: a 10-year prospective study (1992-2001).
Frank M; Gur E; Givon-Lavi N; Peled N; Dagan R; Leibovitz E
Scand J Infect Dis; 2005; 37(3):177-83. PubMed ID: 15849049
[TBL] [Abstract][Full Text] [Related]
39. Cefepime monotherapy for treatment of febrile neutropenia in children.
Ariffin H; Ai CL; Lee CL; Abdullah WA
J Paediatr Child Health; 2006 Dec; 42(12):781-4. PubMed ID: 17096713
[TBL] [Abstract][Full Text] [Related]
40. Bacteraemia in febrile neutropenic cancer patients.
Klastersky J; Ameye L; Maertens J; Georgala A; Muanza F; Aoun M; Ferrant A; Rapoport B; Rolston K; Paesmans M
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S51-9. PubMed ID: 17689933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]